Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Mallinckrodt
Fish and Richardson
Colorcon
Fuji
Chubb
Merck
Moodys
Farmers Insurance

Generated: December 13, 2018

DrugPatentWatch Database Preview

Litigation Details for FEDERAL TRADE COMMISSION v. ABBVIE INC (E.D. Pa. 2014)

« Back to Dashboard

FEDERAL TRADE COMMISSION v. ABBVIE INC (E.D. Pa. 2014)

Docket ➤ Try a Free Trial Date Filed 2014-09-08
Court District Court, E.D. Pennsylvania Date Terminated
Cause 15:0053 Federal Trade Commission Act Assigned To Harvey Bartle III
Jury Demand None Referred To
Parties ABBOTT LABORATORIES; ABBVIE INC; BESINS HEALTHCARE, INC.; FEDERAL TRADE COMMISSION; TEVA PHARMACEUTICALS USA, INC.; UNIMED PHARMACEUTICALS, LLC
Patents 6,503,894; 8,466,136; 8,466,137; 8,466,138; 8,486,925; 8,729,057; 8,741,881; 8,754,070; 8,759,329; 9,125,816; 9,132,089
Attorneys ADAM R. LAWTON; CHRISTOPHER T. HOLDING; DANIEL J. WALKER; DANIEL S. BRADLEY; DANIEL WALKER; ELAINE J. GOLDENBERG; GARTH HUSTON; GREGORY E. NEPPL; GREGORY L. SKIDMORE; GUHA KRISHNAMURTHI; HANNAH LAMB; HEATHER M. JOHNSON; JAMES H WEINGARTEN; JAY P. LEFKOWITZ; JEFFREY I. WEINBERGER; JOHN S. YI; JORDY J HUR; JOSEPH E. WOLFSON; KARA L MONAHAN; LAUREN K. PEAY; LIANE M. PETERSON; MARKUS BRAZILL; MARKUS MEIER; MATTHEW B. WEPRIN; MELINDA F. LEVITT; PATRICIA M MCDERMOTT; PAUL H. SAINT-ANTOINE; PETER J. TAYLOR; RANDALL G. SOMMER; REBECCA L EGELAND; SARAH K. FREDERICK; STUART N. SENATOR; THOMAS D. MAYS; TODD NOLAN HUTCHISON
Firms Christopher T. Holding; Daniel S. Bradley; Drinker Biddle and Reath LLP; Federal Trade Commission; Foley & Lardner; Foley & Lardner LLP; Goodwin Procter LLP; Kirkland & Ellis LLP; Kirkland and Ellis LLP; Munger Tolles & Olson LLP; Munger, Tolles & Olson LLP; Sarah K. Frederick; Stevens & Lee; Stevens & Lee, PC; U.S. Federal Trade Commission
Link to Docket External link to docket
Small Molecule Drugs cited in FEDERAL TRADE COMMISSION v. ABBVIE INC
The small molecule drug covered by the patents cited in this case is ➤ Try a Free Trial .

Details for FEDERAL TRADE COMMISSION v. ABBVIE INC (E.D. Pa. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-09-08 1 pharmaceutical composition patent relating to AndroGel, U.S. Patent No. 6,503,894 (the “’894 Patent”). To obtain this… this patent, Unimed and Besins were required by the U.S. Patent and Trademark Offlce (“PTO”) to significantly…. Aware of the patent’s narrow scope, Perrigo and Teva designed around the ’894 Patent, developing generic…while prosecuting the ’894 Patent before the PTO in order to obtain the ’894 Patent. Abeie Defendants and …their products infringe the ’894 Patent is without merit. ln the patent litigation, Teva counterclaimed External link to document
2015-08-25 118 7 Besins together hold U.S. Patent No. 6,503,894 (the “‘894 Patent”) for a popular brand-name testosterone…infringe GSK’s patent or that the patent was unenforceable. GSK responded by filing patent infringement…of the patent. The FTC alleges that Abbott, Unimed, and Besins initiated sham patent infringement…up its patent challenge by offering an early entry date for AndroGel, the subject of the patent litigation…the extent it was based on the settlement of the patent litigation. The External link to document
2015-12-14 145 Unimed”) and Besins obtained U.S. Patent No. 6,503,894 (“the ‘894 patent”) for the brand-name testosterone…referenced by name in the ‘894 patent. We do not opine on whether or not the ‘894 patent covers additional penetration…recent meeting with patent examiner and examiner’s decision regarding allowing patent.” The email was…a United States Patent and Trademark Office examiner to Mahoney concerning the patent application. …its patent claims were narrowed to a single penetration enhancer at the time it filed the patent infringement External link to document
2016-08-25 220 LLC (“Unimed”) and Besins obtained U.S. Patent Number 6,503,894 has withdrawn claims of privilege in…that the AbbVie defendants and Besins filed sham patent infringement actions against Teva and Perrigo …entered into an anticompetitive settlement of that patent litigation. In January 2003, Unimed …Document 220 Filed 08/25/16 Page 3 of 35 (“the ‘894 patent”) for the brand-name testosterone drug, AndroGel…2011 and October 2011, AbbVie and Besins filed patent infringement lawsuits against Teva and Perrigo External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Cantor Fitzgerald
UBS
McKesson
McKinsey
Daiichi Sankyo
Argus Health
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.